Scientometric study of dynamics of scientific publications on treatment of COVID-19 in the first half of 2020
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/10661 |
Resumo: | The first infection caused by the new coronavirus occurred in China in December 2019. Since then, the search for COVID-19 treatment has become the target of international research. Although studies began shortly after the viral outbreak in China, publications of these studies were expected to increase worldwide after the World Health Organization's statement on the pandemic state of the disease. Thus, this study aimed to analyze the dynamics of scientific publications on the treatment of COVID-19 in the first half of 2020. For data collection, the MEDLINE platform was used through PubMed; the descriptors adopted were: "COVID-19 and Treatment" and "SARS-CoV-2 and Treatment", restricting the publication period from 01/01/2020 to 30/06/2020. Data showed that in January 2020, the initial phase of the pandemic, the number of publications on the subject was small compared to June, with the pandemic totally disseminated. The largest increase in the number of publications occurred between February and March (8.3 times higher). Regarding the number of countries involved in publications, it is observed that in January, three countries were involved; while in May there were 41 countries. In the period analyzed, China led with 152 publications, followed by the United States (141). This may be the result of the emergence of the first cases of the disease and the socioeconomic character of both, which despite the different political regimes, have scientific research as an important point for the continuity of development. |
id |
UNIFEI_c2de0fc8f5c3d97288d235910aeaac21 |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/10661 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
Scientometric study of dynamics of scientific publications on treatment of COVID-19 in the first half of 2020Estudio cienciométrico del dinámica de comportamiento de las publicaciones relativas al tratamiento del COVID-19 en el primer semestre de 2020Estudo cienciométrico da dinâmica comportamental das publicações referentes ao tratamento da COVID-19 no primeiro semestre de 2020COVID-19Scienciometric studyTreatment.COVID-19Estudio cienciométricoTratamiento.COVID-19Estudo cienciométricoTratamento.The first infection caused by the new coronavirus occurred in China in December 2019. Since then, the search for COVID-19 treatment has become the target of international research. Although studies began shortly after the viral outbreak in China, publications of these studies were expected to increase worldwide after the World Health Organization's statement on the pandemic state of the disease. Thus, this study aimed to analyze the dynamics of scientific publications on the treatment of COVID-19 in the first half of 2020. For data collection, the MEDLINE platform was used through PubMed; the descriptors adopted were: "COVID-19 and Treatment" and "SARS-CoV-2 and Treatment", restricting the publication period from 01/01/2020 to 30/06/2020. Data showed that in January 2020, the initial phase of the pandemic, the number of publications on the subject was small compared to June, with the pandemic totally disseminated. The largest increase in the number of publications occurred between February and March (8.3 times higher). Regarding the number of countries involved in publications, it is observed that in January, three countries were involved; while in May there were 41 countries. In the period analyzed, China led with 152 publications, followed by the United States (141). This may be the result of the emergence of the first cases of the disease and the socioeconomic character of both, which despite the different political regimes, have scientific research as an important point for the continuity of development.La primera infección causada por el nuevo coronavirus ocurrió en China, en diciembre de 2019. Desde entonces, la búsqueda por los tratamientos para la COVID-19 se convirtió en el objetivo de las investigaciones internacionales. Aunque los estudios han comenzado poco después del brote viral en China, el aumento de las publicaciones de estos estudios en todo el mundo se esperaba después de la declaración de la Organización Mundial de la Salud sobre el estado pandémico de la enfermedad. Así, este estudio tuvo como objetivo analizar la dinámica de las publicaciones científicas sobre el tratamiento de la COVID-19 en el primer semestre de 2020. Para la recolección de datos se utilizó la plataforma MEDLINE a través de PubMed; los descriptores adoptados fueron: “COVID-19 y Tratamiento” y “SARS-CoV-2 y Tratamiento”, restringiendo el período de publicación del 01/01/2020 al 30/06/2020. Los datos mostraron que en enero de 2020, fase inicial de la pandemia, el número de publicaciones sobre el tema fue diminuto en comparación con junio, con la pandemia totalmente diseminada. El mayor crecimiento en el número de publicaciones ocurrió entre febrero y marzo (8,3 veces mayor). Al que se refiere el número de países involucrados en publicaciones, se observa que en enero participaron tres países; mientras que en mayo había 41 países. En el período analizado, China lideró con 152 publicaciones, seguida del Estados Unidos (141). Esto puede ser resultado del surgimiento de los primeros casos de la enfermedad y del carácter socioeconómico de ambos, que a pesar de los diferentes regímenes políticos, tienen la investigación científica como un punto importante para la continuidad del desarrollo.A primeira infecção causada pelo novo coronavírus ocorreu na China, em dezembro de 2019. Desde então, a busca por tratamentos para a COVID-19 tornou-se alvo de pesquisas internacionais. Apesar dos estudos terem iniciado logo após o surto viral na China, era esperado o aumento das publicações desses estudos pelo mundo todo após a declaração da Organização Mundial de Saúde sobre o estado pandêmico da doença. Dessa forma, este estudo teve como objetivo analisar a dinâmica das publicações científicas sobre o tratamento da COVID-19 no primeiro semestre de 2020. Para a coleta de dados utilizou-se a plataforma MEDLINE por meio da PubMed; os descritores adotados foram: “COVID-19 and Treatment” e “SARS-CoV-2 and Treatment”, restringindo o período de publicação de 01/01/2020 a 30/06/2020. Dados mostraram que em janeiro de 2020, fase inicial da pandemia, o número de publicações sobre o tema foi ínfimo em relação a junho, com a pandemia totalmente disseminada. O maior crescimento no número de publicações ocorreu entre fevereiro e março (8,3 vezes maior). No que se refere ao número de países envolvidos em publicações, observa-se que em janeiro, três países estavam envolvidos; enquanto, em maio havia 41 países. No período analisado, a China liderou com 152 publicações, seguida pelos Estados Unidos (141). Isso pode ser resultado do surgimento dos primeiros casos da doença e do caráter socioeconômico de ambos, que apesar dos distintos regimes políticos, têm a pesquisa científica como ponto importante para a continuidade do desenvolvimento.Research, Society and Development2020-12-10info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/1066110.33448/rsd-v9i11.10661Research, Society and Development; Vol. 9 No. 11; e97591110661Research, Society and Development; Vol. 9 Núm. 11; e97591110661Research, Society and Development; v. 9 n. 11; e975911106612525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/10661/9557Copyright (c) 2020 Ghabriel Luiz Bellotto; Bruna Spironello Anschau; Camilla Scott Moereira; Juliane Toffoli Silva; Kádima Nayara Teixeirahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessBellotto, Ghabriel LuizAnschau, Bruna Spironello Moereira, Camilla Scott Silva, Juliane Toffoli Teixeira, Kádima Nayara2020-12-10T23:37:57Zoai:ojs.pkp.sfu.ca:article/10661Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:32:40.664094Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
Scientometric study of dynamics of scientific publications on treatment of COVID-19 in the first half of 2020 Estudio cienciométrico del dinámica de comportamiento de las publicaciones relativas al tratamiento del COVID-19 en el primer semestre de 2020 Estudo cienciométrico da dinâmica comportamental das publicações referentes ao tratamento da COVID-19 no primeiro semestre de 2020 |
title |
Scientometric study of dynamics of scientific publications on treatment of COVID-19 in the first half of 2020 |
spellingShingle |
Scientometric study of dynamics of scientific publications on treatment of COVID-19 in the first half of 2020 Bellotto, Ghabriel Luiz COVID-19 Scienciometric study Treatment. COVID-19 Estudio cienciométrico Tratamiento. COVID-19 Estudo cienciométrico Tratamento. |
title_short |
Scientometric study of dynamics of scientific publications on treatment of COVID-19 in the first half of 2020 |
title_full |
Scientometric study of dynamics of scientific publications on treatment of COVID-19 in the first half of 2020 |
title_fullStr |
Scientometric study of dynamics of scientific publications on treatment of COVID-19 in the first half of 2020 |
title_full_unstemmed |
Scientometric study of dynamics of scientific publications on treatment of COVID-19 in the first half of 2020 |
title_sort |
Scientometric study of dynamics of scientific publications on treatment of COVID-19 in the first half of 2020 |
author |
Bellotto, Ghabriel Luiz |
author_facet |
Bellotto, Ghabriel Luiz Anschau, Bruna Spironello Moereira, Camilla Scott Silva, Juliane Toffoli Teixeira, Kádima Nayara |
author_role |
author |
author2 |
Anschau, Bruna Spironello Moereira, Camilla Scott Silva, Juliane Toffoli Teixeira, Kádima Nayara |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Bellotto, Ghabriel Luiz Anschau, Bruna Spironello Moereira, Camilla Scott Silva, Juliane Toffoli Teixeira, Kádima Nayara |
dc.subject.por.fl_str_mv |
COVID-19 Scienciometric study Treatment. COVID-19 Estudio cienciométrico Tratamiento. COVID-19 Estudo cienciométrico Tratamento. |
topic |
COVID-19 Scienciometric study Treatment. COVID-19 Estudio cienciométrico Tratamiento. COVID-19 Estudo cienciométrico Tratamento. |
description |
The first infection caused by the new coronavirus occurred in China in December 2019. Since then, the search for COVID-19 treatment has become the target of international research. Although studies began shortly after the viral outbreak in China, publications of these studies were expected to increase worldwide after the World Health Organization's statement on the pandemic state of the disease. Thus, this study aimed to analyze the dynamics of scientific publications on the treatment of COVID-19 in the first half of 2020. For data collection, the MEDLINE platform was used through PubMed; the descriptors adopted were: "COVID-19 and Treatment" and "SARS-CoV-2 and Treatment", restricting the publication period from 01/01/2020 to 30/06/2020. Data showed that in January 2020, the initial phase of the pandemic, the number of publications on the subject was small compared to June, with the pandemic totally disseminated. The largest increase in the number of publications occurred between February and March (8.3 times higher). Regarding the number of countries involved in publications, it is observed that in January, three countries were involved; while in May there were 41 countries. In the period analyzed, China led with 152 publications, followed by the United States (141). This may be the result of the emergence of the first cases of the disease and the socioeconomic character of both, which despite the different political regimes, have scientific research as an important point for the continuity of development. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-12-10 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/10661 10.33448/rsd-v9i11.10661 |
url |
https://rsdjournal.org/index.php/rsd/article/view/10661 |
identifier_str_mv |
10.33448/rsd-v9i11.10661 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/10661/9557 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 9 No. 11; e97591110661 Research, Society and Development; Vol. 9 Núm. 11; e97591110661 Research, Society and Development; v. 9 n. 11; e97591110661 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052782518206464 |